Valuation Roche Holding AG London S.E.

Stocks

Market Closed - London S.E. Other stock markets 19:20:00 25/06/2026 +04			5-day change	1st Jan Change
323.90 ^CHF	0.00%		0.00%	-1.29%

06-24	Ollin raises $330 million to fund late-stage eye disease drug trials	RE
06-23	THX Pharma appoints Sophie Jacq Lapointe to its board of directors

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	306,810	239,812	197,073	205,191	262,098	267,656	-	-
Change	-	-21.84%	-17.82%	4.12%	27.73%	2.12%	-	-
Enterprise Value (EV) ¹	324,977	255,396	215,772	222,528	278,258	278,090	271,412	263,723
Change	-	-21.41%	-15.51%	3.13%	25.04%	-0.06%	-2.4%	-2.83%
P/E	23.4x	18.9x	17.1x	24.8x	20.5x	17.9x	16.7x	15.4x
PBR	13.2x	8.29x	5.91x	5.67x	7.8x	6.64x	5.6x	4.76x
PEG	-	-3.69x	-2.48x	-0.9x	0.4x	1.1x	2.42x	1.82x
Capitalization / Revenue	4.89x	3.79x	3.36x	3.39x	4.26x	4.28x	4.11x	3.92x
EV / Revenue	5.17x	4.04x	3.67x	3.68x	4.52x	4.45x	4.17x	3.87x
EV / EBITDA	13.2x	10.2x	9.82x	9.45x	11.3x	10.9x	10x	9.17x
EV / EBIT	14.8x	11.5x	11.2x	10.7x	12.7x	12.3x	11.2x	10.3x
EV / FCF	20.7x	19.6x	19.1x	14.5x	23.6x	17.9x	16.6x	14.9x
FCF Yield	4.83%	5.11%	5.23%	6.89%	4.24%	5.58%	6.02%	6.69%
Dividend per Share ²	9.3	9.5	9.6	9.7	9.8	10.01	10.25	10.52
Rate of return	2.45%	3.27%	3.93%	3.8%	2.99%	2.99%	3.06%	3.14%
EPS ²	16.2	15.37	14.31	10.31	16.04	18.77	20.06	21.76
Distribution rate	57.4%	61.8%	67.1%	94.1%	61.1%	53.4%	51.1%	48.4%
Net sales ¹	62,801	63,281	58,716	60,495	61,516	62,557	65,058	68,207
EBITDA ¹	24,692	25,015	21,976	23,538	24,608	25,443	27,124	28,764
EBIT ¹	21,897	22,173	19,240	20,823	21,833	22,547	24,140	25,685
Net income ¹	13,930	12,421	11,498	8,277	12,880	15,225	16,245	17,443
Net Debt ¹	18,167	15,584	18,699	17,337	16,160	10,433	3,756	-3,933
Reference price ²	379.10	290.50	244.50	255.50	328.20	335.30	335.30	335.30
Nbr of stocks (in thousands)	800,952	800,579	798,652	796,789	796,317	795,618	-	-
Announcement Date	03/02/22	02/02/23	01/02/24	30/01/25	29/01/26	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.55x	11.89x	24.17x	0.61%	996B
JOHNSON & JOHNSON	25.76x	5.93x	16.13x	2.21%	580B
ABBVIE INC.	29.68x	6.99x	14.31x	2.95%	415B
ASTRAZENECA PLC	22.95x	4.79x	13.58x	1.82%	284B
NOVARTIS AG	21.2x	5.48x	13.29x	2.92%	280B
NOVO NORDISK A/S	13.82x	5.11x	10.52x	3.64%	210B
AMGEN INC.	22.85x	6.11x	10.67x	2.87%	190B
GILEAD SCIENCES, INC.	-44.84x	5.41x	29.86x	2.59%	155B
PFIZER INC.	11.24x	3x	7.31x	7.29%	137B
Average	15.02x	6.08x	15.54x	2.99%	360.83B
Weighted average by Cap.	22.77x	7.57x	17.50x	2.21%